Stevens Capital Management LP Makes New Investment in Henry Schein, Inc. (NASDAQ:HSIC)

Stevens Capital Management LP purchased a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 5,196 shares of the company’s stock, valued at approximately $393,000.

Other institutional investors also recently added to or reduced their stakes in the company. Aurora Investment Counsel lifted its holdings in shares of Henry Schein by 0.7% in the third quarter. Aurora Investment Counsel now owns 20,641 shares of the company’s stock valued at $1,533,000 after buying an additional 140 shares during the period. Arizona State Retirement System raised its position in shares of Henry Schein by 0.4% during the fourth quarter. Arizona State Retirement System now owns 35,890 shares of the company’s stock worth $2,717,000 after purchasing an additional 149 shares during the period. Allspring Global Investments Holdings LLC raised its position in shares of Henry Schein by 1.8% during the third quarter. Allspring Global Investments Holdings LLC now owns 10,798 shares of the company’s stock worth $802,000 after purchasing an additional 194 shares during the period. Thompson Investment Management Inc. raised its position in shares of Henry Schein by 2.3% during the third quarter. Thompson Investment Management Inc. now owns 8,840 shares of the company’s stock worth $656,000 after purchasing an additional 200 shares during the period. Finally, Wahed Invest LLC raised its position in shares of Henry Schein by 11.3% during the third quarter. Wahed Invest LLC now owns 2,035 shares of the company’s stock worth $151,000 after purchasing an additional 206 shares during the period. Institutional investors and hedge funds own 96.62% of the company’s stock.

Henry Schein Trading Up 0.4 %

NASDAQ HSIC traded up $0.31 on Friday, reaching $73.13. The company had a trading volume of 722,374 shares, compared to its average volume of 1,079,516. The firm has a market cap of $9.40 billion, a price-to-earnings ratio of 23.12, a P/E/G ratio of 1.81 and a beta of 0.87. Henry Schein, Inc. has a fifty-two week low of $60.01 and a fifty-two week high of $82.63. The business has a 50 day moving average of $74.23 and a two-hundred day moving average of $72.43. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.67 and a quick ratio of 1.00.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, February 27th. The company reported $0.66 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.70 by ($0.04). The company had revenue of $3.02 billion for the quarter, compared to the consensus estimate of $3 billion. Henry Schein had a return on equity of 14.03% and a net margin of 3.37%. Henry Schein’s revenue for the quarter was down 10.5% compared to the same quarter last year. During the same period last year, the company earned $1.21 EPS. Analysts forecast that Henry Schein, Inc. will post 5.07 EPS for the current year.

Insider Buying and Selling

In related news, Vice Chairman James P. Breslawski sold 2,907 shares of Henry Schein stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $74.37, for a total value of $216,193.59. Following the sale, the insider now owns 209,562 shares of the company’s stock, valued at approximately $15,585,125.94. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of the business’s stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total transaction of $477,620.40. Following the sale, the chief executive officer now owns 73,108 shares of the company’s stock, valued at approximately $5,430,462.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the business’s stock in a transaction on Monday, March 18th. The shares were sold at an average price of $74.37, for a total transaction of $216,193.59. Following the sale, the insider now directly owns 209,562 shares in the company, valued at approximately $15,585,125.94. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of brokerages have recently issued reports on HSIC. Piper Sandler boosted their target price on Henry Schein from $78.00 to $86.00 and gave the stock an “overweight” rating in a research report on Monday, February 26th. Jefferies Financial Group upped their price target on Henry Schein from $74.00 to $81.00 and gave the stock a “hold” rating in a research note on Wednesday, March 6th. TheStreet upgraded Henry Schein from a “c+” rating to a “b-” rating in a research note on Monday, February 26th. Leerink Partnrs restated a “market perform” rating on shares of Henry Schein in a research note on Monday, February 26th. Finally, SVB Leerink started coverage on Henry Schein in a research report on Monday, February 26th. They issued a “market perform” rating and a $78.00 price objective for the company. One research analyst has rated the stock with a sell rating, six have issued a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $81.09.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.